JPMorgan Chase & Co. Reduces Holdings in Caris Life Sciences, Inc. $CAI
JPMorgan Chase & Co. lowered its position in Caris Life Sciences, Inc. (NASDAQ:CAI - Free Report) by 8.2% in the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 858,105 shares of the company's stock after selling 76,528 shares during the quarter. JPMorga...